Pancreatic Cancer
📧 Sign up to get email alerts when something new happens for Pancreatic Cancer.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS research · 2019-01-29Clinical Trial Update: Evaluation of MMR Status and PD-L1 Expression Using Specimens Obtained by EUS-FNB in Patients With Pancreatic Cancer
This clinical trial is evaluating mismatch repair (MMR) status and PD-L1 expression in pancreatic cancer using specimens obtained by endosco…
-
CLINICAL_TRIALS trial_result · 2019-01-28Clinical Trial Update: Efficacy and Safety of Endobiliary Radiofrequency Ablation by Using a Novel RF Catheter (ELRA®) on Maintaining the Patency of Endobiliary Metal Drainage in Patients With Malignant Biliary Strictures : A Double-arm Comparable Study [NA]
This clinical trial update discusses the efficacy and safety of a novel endobiliary radiofrequency ablation catheter (ELRA) used to maintain…
-
CLINICAL_TRIALS research · 2019-01-28Clinical Trial Update: A Study for Efficacy of Side-by-side Compared to Stent-in-stent Technique in the Endoscopic Management of Malignant Hilar Biliary Obstruction [NA]
A clinical trial comparing side-by-side versus stent-in-stent techniques for malignant hilar biliary obstruction. The study lists cholangioc…
-
CLINICAL_TRIALS trial_result · 2019-01-25Clinical Trial Update: Nab-paclitaxel Combined With S-1 as Induction Therapy for Locally Advanced Pancreatic Cancer [Phase 2]
Phase 2 trial evaluating nab-paclitaxel in combination with S-1 as induction therapy for locally advanced pancreatic cancer; current status …
-
CLINICAL_TRIALS trial_result · 2019-01-25Clinical Trial Update: Observational Study of Quality of Live in Patients With Metastatic Pancreatic Cancer
This completed observational study assessed quality of life in patients with metastatic pancreatic cancer.
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS research · 2019-01-25Clinical Trial Update: Mutation of K-RAS, CDKN2A, SMAD4 and TP53 in Pancreatic Cancer: Role of Liquid Biopsy in Preoperative Diagnosis
The update discusses mutations in K-RAS, CDKN2A, SMAD4, and TP53 in pancreatic cancer and evaluates liquid biopsy for preoperative diagnosis…
-
CLINICAL_TRIALS research · 2019-01-25Clinical Trial Update: Bioinformation Therapy for Pancreatic Cancer [Phase 2, Phase 3]
This clinical trial update reports the completion of Phase 2 and Phase 3 testing of a bioinformation therapy for unresectable pancreatic can…
-
CLINICAL_TRIALS trial_result · 2019-01-23Clinical Trial Update: Neoadjuvant Accelerated Short Course Radiation Therapy With Proton Beam and Capecitabine for Resectable Pancreatic Cancer [Phase 1, Phase 2]
This study evaluates neoadjuvant accelerated short-course radiation therapy with proton beam therapy plus capecitabine for resectable pancre…
-
CLINICAL_TRIALS trial_result · 2019-01-23Clinical Trial Update: Gemcitabine/Taxotere/Xeloda (GTX) With Cisplatin in Subjects With Metastatic Pancreatic Cancer [Phase 2]
Phase 2 trial update of GTX (gemcitabine/taxotere/xeloda) with cisplatin in metastatic pancreatic cancer completed; results posted.
-
CLINICAL_TRIALS research · 2019-01-23Clinical Trial Update: SurePathTM Liquid-based Cytology and Conventional Smear Cytology in Pancreatic Lesions
This clinical trial compares SurePath liquid-based cytology with conventional smear cytology for evaluating pancreatic lesions in pancreatic…
-
CLINICAL_TRIALS trial_result · 2019-01-22Clinical Trial Update: Registry Study - Whipple at the Splenic Artery
A registry study evaluating the Whipple procedure at the splenic artery for pancreatic cancer has completed.
-
CLINICAL_TRIALS trial_result · 2019-01-18Clinical Trial Update: Safety Study to Determine the Appropriate Dose of Antibody Against Tumor Cells to Best Target Patients With Pancreatic Cancer. [EARLY_Phase 1]
This update notes the termination of an early-phase safety study evaluating an antibody for pancreatic cancer to determine the appropriate d…
-
CLINICAL_TRIALS trial_result · 2019-01-17Clinical Trial Update: Nab-Paclitaxel Plus Gemcitabine Versus Gemcitabine For The First Line Treatment of Pancreas Cancer [Phase 2]
This document notes a completed Phase 2 trial comparing nab-paclitaxel plus gemcitabine versus gemcitabine alone as first-line therapy for p…
-
CLINICAL_TRIALS research · 2019-01-17Clinical Trial Update: Registry of Pancreatic Disease
This entry notes an ongoing registry study on pancreatic diseases, including pancreatic neoplasms and pancreatitis, sponsored by Azienda Osp…
-
CLINICAL_TRIALS trial_result · 2019-01-11Clinical Trial Update: Clinical Study on Anti-tumor Effect Induced by Activated Primary Natural Killer（NK）Cells [Phase 1, Phase 2]
Clinical trial update for an activated primary natural killer cell therapy showing intent to assess anti-tumor effects in multiple cancers i…
-
CLINICAL_TRIALS trial_result · 2019-01-08Clinical Trial Update: Phase 2 Nab® -Paclitaxel (Abraxane®) Plus Gemcitabine in Subjects With Locally Advanced Pancreatic Cancer (LAPC) [Phase 2]
Phase 2 trial update for nab-paclitaxel plus gemcitabine in locally advanced pancreatic cancer has completed with results posted.
-
CLINICAL_TRIALS trial_result · 2019-01-03Clinical Trial Update: A Multi-Center Study of Ibrutinib in Combination With MEDI4736 in Subjects With Relapsed or Refractory Solid Tumors [Phase 1, Phase 2]
Phase 1/2 trial evaluating ibritinib in combination with MEDI4736 in relapsed/refractory solid tumors completed with results posted in 2019.
-
CLINICAL_TRIALS trial_result · 2018-12-17Clinical Trial Update: Masitinib in Combination With Gemcitabine for Treatment of Patients With Advanced/Metastatic Pancreatic Cancer [Phase 3]
A Phase 3 clinical trial evaluating masitinib in combination with gemcitabine for advanced/metastatic pancreatic cancer has completed.
-
CLINICAL_TRIALS trial_result · 2018-12-17Clinical Trial Update: Tosedostat With Capecitabine in Patients With Metastatic Pancreatic Adenocarcinoma [Phase 1, Phase 2]
Clinical trial update for tosedostat with capecitabine in metastatic pancreatic adenocarcinoma (Phase 1/2); study terminated with posted res…
-
CLINICAL_TRIALS trial_result · 2018-12-11Clinical Trial Update: FOLFIRINOX in Metastatic High Grade Gastroenteropancreatic Neuroendocrine Carcinomas [Phase 2]
Phase 2 trial of FOLFIRINOX in metastatic high-grade gastroenteropancreatic neuroendocrine carcinomas was terminated; results posted in 2018…
-
CLINICAL_TRIALS trial_result · 2018-11-30Clinical Trial Update: Pemetrexed, Gemcitabine, and Radiation Therapy in Treating Patients With Locally Advanced Pancreatic Cancer [Phase 1]
Phase 1 trial evaluating pemetrexed, gemcitabine, and radiation therapy in locally advanced pancreatic cancer; study terminated with results…
-
CLINICAL_TRIALS trial_result · 2018-11-30Clinical Trial Update: Study of Gemcitabine + PEGPH20 vs Gemcitabine Alone in Stage IV Previously Untreated Pancreatic Cancer [Phase 1, Phase 2]
Phase 1/2 study evaluating gemcitabine with PEGPH20 versus gemcitabine alone in stage IV pancreatic cancer has completed with results posted…
-
CLINICAL_TRIALS trial_result · 2018-11-19Clinical Trial Update: A Study of LY2090314 and Chemotherapy in Participants With Metastatic Pancreatic Cancer [Phase 1, Phase 2]
Clinical trial update for LY2090314 with chemotherapy in metastatic pancreatic cancer (Phase 1/2) terminated; results posted.
-
CLINICAL_TRIALS trial_result · 2018-11-15Clinical Trial Update: BP-C1 in Short-term Treatment of Metastatic Pancreatic Cancer [Phase 2]
Phase 2 clinical trial update for BP-C1 in metastatic/unresectable pancreatic cancer has completed.
-
CLINICAL_TRIALS trial_result · 2018-10-31Clinical Trial Update: Gemcitabine and Celecoxib in Treating Patients With Metastatic Pancreatic Cancer [Phase 2]
Phase 2 clinical trial updating gemcitabine and celecoxib in metastatic pancreatic cancer completed.